Prednisolone augments superoxide formation in porcine pulmonary artery endothelial cells through differential effects on the expression of nitric oxide synthase and NADPH oxidase

British Journal of Pharmacology

Volumn 145, Issue 5, 2005, Pages 688-697

  Muzaffar, Saima ^a   Shukla, Nilima ^a   Angelini, Gianni D ^a   Jeremy, Jamie Y ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

eNOS; NADPH oxidase; Pig pulmonary artery; Prednisolone; Superoxide

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; 8 (4 CHLOROPHENYLTHIO) CYCLIC AMP; ACETYLSALICYLIC ACID; ALLOPURINOL; ANTIINFLAMMATORY AGENT; APOCYNIN; CYCLIC GMP; CYCLIC GMP DERIVATIVE; DIPHENYLIODONIUM SALT; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENZYME INHIBITOR; GUANYLATE CYCLASE INHIBITOR; IMINE; LINSIDOMINE; MORPHOLINE DERIVATIVE; MORPHOLINOSYDNONIMINE; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRITE; PREDNISOLONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; ROTENONE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; XANTHINE OXIDASE INHIBITOR;

ADULT RESPIRATORY DISTRESS SYNDROME; ANIMAL CELL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; ASSAY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME ACTIVITY; FLUORESCENCE ANALYSIS; GENE EXPRESSION REGULATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY ARTERY; SPECTROPHOTOMETRY; SWINE; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; NADPH OXIDASE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE III; PREDNISOLONE; PULMONARY ARTERY; SUPEROXIDES; SWINE;

EID: 22744434838     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0706235     Document Type: Article

References (36)

1. BERNARD, G.R., LUCE, J.M., SPRUNG, C.L., RINALDO, J.E., TATE, R.M., SIBBALD, W.J., KARIMAN, K., HIHGGINS, S., BRADLEY, R. & METZ, C.A. (1987). High-dose corticosteroids in patients with the adult respiratory distress syndrome. N. Engl. J. Med., 317, 1565-1570.
2. BJORGVINSDOTTIR, H., ZHEN, L. & DINAUER, M.C. (1996). Cloning of murine gp91phox cDNA and functional expression in a human X-linked chronic granulomatous disease cell line. Blood, 87, 2005-2010.
3. BONE, R.C., FISCHER, J.C.J., CLEMMER, T.P., SLOTMAN, G.J. & METZ, C.A. (1987). Early methylprednisolone treatment for septic syndrome and the adult respiratory distress syndrome. Chest, 92, 1032-1036.
4. CHABOT, F., MITCHELL, J.A., GUTTERIDGE, J.M.C. & EVANS, A.M. (1998). Reactive oxygen species in acute lung injury. Eur. Respir. J., 11, 745-757.
5. FOLKERTS, G., KLOEK, J., MUIJSERS, R.B. & NIJKAMP, P.P. (2001). Reactive nitrogen and oxygen species in airway inflammation. Eur. J. Pharmacol., 429, 251-262.
6. •- in posthypoxic injury of renal epithelial cells. Am. J. Physiol., 263, F251-F255.
7. GRIENDLING, K.K., MINIERI, C.A., OLLERENSHAW, J.D. & ALEXANDER, R.W. (1994). Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res., 74, 1141-1148.
8. JANTZ, M.A. & SHAN, S.A. (1999). Corticosteroids in acute respiratory failure. Am. J. Respir. Crit. Care Med., 160, 1079-1100.
9. JEREMY, J.Y., ROWE, D., EMSLEY, A.M. & NEWBY, A.C. (1999). Nitric oxide and the proliferation of vascular smooth muscle cells. Cardiovasc. Res., 43, 580-594.
10. KLINGER, J.R. (2002). Inhaled nitric oxide in ARDS. Crit. Care Clin., 18, 45-68.
11. LEIKERT, J.F., RATHEL, T.R., MULLER, C., VOLLMAR, A.M. & DIRSCH, V.M. (2001). Reliable in vitro measurement of nitric oxide released from endothelial cells using low concentrations of the fluorescent probe 4,5-diaminofluorescein. FEBS Lett., 506, 131-134.
12. 2 in sheep with acute lung injury after high dose endotoxin infusion. Am. Rev. Respir. Dis., 148, 878-881.
13. LOPEZ, A., LORENTE, J.A., STEINGRUB, J., BAKKER, J., MCLUCKIE, A., WILLATTS, S., BROCKWAY, M., ANZUETO, A., HOLZAPFEL, L., BREEN, D., SILVERMAN, M.S., TAKALA, J., DONALDSON, J., ARNESON, C., GROVE, G., GROSSMAN, S. & GROVER, R. (2004). Multiple-center, randomized, placebo-controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: effect on survival in patients with septic shock. Crit. Care Med., 32, 21-30.
14. LUCE, J.M., MONTGOMERY, A.B., MARKS, J.D., TURNER, C.A., METZ, C.A. & MURRAY, J.F. (1988). Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with sepsis. Am. Rev. Respir. Dis., 138, 62-68.
15. MARUMO, T., SCHINI-KERTH, V.B., BRANDES, R.P. & BUSSE, R. (1998). Glucocorticoids inhibit superoxide anion production and p22 phox mRNA expression in human aortic smooth muscle cells. Hypertension, 32, 1083-1088.
16. MEDURI, G.U. & CHROUSOS, G.P. (1998). Duration of glucocorticoid treatment and outcome in sepsis: is the right drug used the wrong way? Chest, 114, 355-360.
17. MEIER, B., RADEKE, H.H., SELLE, S., YOUNES, M., SIES, H., RESCH, K. & HABERMEHL, G.G. (1989). Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-alpha. Biochem. J., 263, 539-545.
18. MIDDELVELD, R.J., WANECEK, M., BERGMAN, D., WEITZBERG, E. & ALVING, K. (1999). Effect of cortisol-synthesis inhibition on endotoxin-induced porcine acute lung injury, shock, and nitric oxide production. Shock, 12, 382-390.
19. MUZAFFAR, S., JEREMY, J.Y., ANGELINI, G.D., STUART-SMITH, K. & SHUKLA, N. (2003). Role of the endothelium and nitric oxide synthases in modulating superoxide formation induced by endotoxin and cytokines in porcine pulmonary arteries. Thorax, 58, 598-604.
20. MUZAFFAR, S., SHUKLA, N., ANGELINI, G.D. & JEREMY, J.Y. (2004a). Nitroaspirins and morpholinosydnonimine, but not aspirin, inhibit the formation of superoxide and the expression of gp91phox induced by endotoxin and cytokines in pig pulmonary artery vascular smooth muscle cells and endothelial cells. Circulation, 110, 1140-1147.
21. MUZAFFAR, S., SHUKLA, N., ANGELINI, G.D. & JEREMY, J.Y. (2005a). Hypoxia simultaneously induces the expression of gp91phox and endothelial nitric oxide synthase in the pulmonary artery. Thorax, 60, 305-313.
22. MUZAFFAR, S., SHUKLA, N., ANGELINI, G.D. & JEREMY, J.Y. (2005b). Superoxide promotes gp91phox expression in pulmonary artery endothelial cells. Br. J. Pharmacol. (in press).
23. MUZAFFAR, S., SHUKLA, N., LOBO, C., ANGELINI, G.D. & JEREMY, J.Y. (2004b). Iloprost inhibits superoxide formation and gp91phox expression induced by the thromboxane A2 analogue U46619, 8-isoprostane F2a, prostaglandin F2a, cytokines and endotoxin in the pig pulmonary artery. Br. J. Pharmacol., 141, 488-496.
24. NAKATSUBO, N., KOJIMA, H., KIKUCHI, K., NAGOSHI, H., HIRATA, Y., MAEDA, D., IMAI, Y., IRIMURA, T. & NAGANO, T. (1998). Direct evidence of nitric oxide production from bovine aortic endothelial cells using new fluorescence indicators: diamino-fluoresceins. FEBS Lett, 427, 263-266.
25. NEWTON, R. (2000). Molecular mechanisms of glucocorticoid action: what is important? Thorax, 55, 603-613.
26. NIMS, R.W., COOK, J.C., KRISHNA, M.C., CHRISTODOULOU, D., POORE, C.M., MILES, A.M., GRISHAM, M.B. & WINK, D.A. (1996). Colorimetric assays for nitric oxide and nitrogen oxide species formed from nitric oxide stock solutions and donor compounds. Methods Enzymol., 268, 93-105.
27. RATHEL, T.R., LEIKERT, J.J., VOLLMAR, A.M. & DIRSCH, V.M. (2003). Application of 4,5-diaminofluorescein to reliably measure nitric oxide released from endothelial cells in vitro. Biol. Proc. Online, 5, 136-142.
28. ROGERS, K.M., BONAR, C.A., ESTRELLA, J.L. & YANG, S. (2002). Inhibitory effect of glucocorticoid on coronary artery endothelial function. Am. J. Physiol., 283, H1922-H1928.
29. STOLK, J., HILTERMANN, T.J. & DIJKMAN, J.H. (1994). Characteristics of the inhibition of NADPH oxidase activation in neutrophils by apocynin, a methoxy-substituted catechol. Am. J. Respir. Cell. Mol. Biol., 11, 95-102.
30. STUART-SMITH, K. & JEREMY, J.Y. (2001). Microvessel damage in acute respiratory distress syndrome: the answer may not be NO. Br. J. Anaesth., 87, 272-279.
31. TATE, R.M., MORRIS, H.G., SCHROEDER, W.R. & REPINE, J.E. (1984). Oxygen metabolites stimulate thromboxane production and vasoconstriction in isolated saline-perfused rabbit lungs. J. Clin. Invest., 74, 608-613.
32. VERMES, I., BEISHUIZEN, A., HAMPSINK, R.M. & HAANEN, C. (1995). Dissociation of plasma adrenocorticotropin and cortisol levels in critically ill patients: possible role of endothelin and atrial natriuretic hormone. J. Clin. Endocrinol. Metab., 80, 1238-1242.
33. WANG, T., EL KEBIR, D. & BLAISE, G. (2003). Inhaled nitric oxide in 2003: a review of its mechanisms of action. Can. J. Anaesth., 50, 839-846.
34. WEINACKER, A.B. & VASZAR, L.T. (2001). Acute respiratory distress syndrome: physiology and new management strategies. Annu. Rev. Med., 52, 221-237.
35. WEINBERGER, B., LASKIN, D.L., HECK, D.E. & LASKIN, J.D. (2001). The toxicology of inhaled nitric oxide. Toxicol. Sci., 59, 5-16.
36. YU, L., QUINN, M.T., CROSS, A.R. & DINAUER, M.C. (1998). Gp91(phox) is the heme binding subunit of the superoxide-generating NADPH oxidase. Proc. Natl. Acad. Sci. U.S.A., 95, 7993-7998.